Who owns Alnylam Pharmaceuticals (ALNY)? Superinvestor holders
4 superinvestors of the 157 tracked here hold Alnylam Pharmaceuticals (ALNY) in their latest 13F filing, with $2.2B between them. Baillie Gifford team gives it the most weight: 1.28% of the reported portfolio. In their latest reported quarter, Baillie Gifford team, Dodge & Cox team and David Shaw (founder) added; Ray Dalio (founder) reduced.
Ken Fisher sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 4 of 157
- Biggest holder
- Baillie Gifford team, $1.4B
- Largest weight
- Baillie Gifford team, 1.28%of their portfolio
- Combined value
- $2.2B
- Bought last quarter
- 3
- Sold last quarter
- 2
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford teamBaillie Gifford & Co | 1.28% | $1.4B | 5.49M | ▲ Added 125% | +3.05M | Q3 2026 |
| 2 | Dodge & Cox teamDodge & Cox | 0.27% | $495.1M | 2.01M | ▲ Added 2.6% | +51.04K | Q3 2026 |
| 3 | David Shaw (founder)D. E. Shaw & Co. | 0.21% | $332.4M | 1.1M | ▲ Added 4.3% | +45.01K | Q2 2026 |
| 4 | Ray Dalio (founder)Bridgewater Associates | 0.12% | $30M | 99.58K | ▼ Reduced 6.6% | −7K | Q2 2026 |
Sold out last quarter
- Ken Fisherwas $1.9M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 7.5M | $1.9B | 2 | 1 |
| Q2 2026 | 157 | 5 | 7.47M | $2.3B | 2 | 3 |
| Q1 2026 | 157 | 5 | 7.58M | $2.5B | 3 | 3 |
| Q4 2025 | 157 | 6 | 6.63M | $2.6B | 4 | 3 |
| Q3 2025 | 157 | 5 | 7M | $3.2B | 3 | 2 |
| Q2 2025 | 157 | 5 | 7.77M | $2.5B | 3 | 3 |
| Q1 2025 | 156 | 5 | 8.2M | $2.2B | 3 | 2 |
| Q4 2024 | 156 | 3 | 8.39M | $2B | 1 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Baillie Gifford team | 5.49M | 2.44M | 2.49M | 2.6M | 2.79M | 3.03M | 3.66M | 4.04M |
| Dodge & Cox team | 2.01M | 1.96M | 1.93M | 1.96M | 2.32M | 3.2M | 3.35M | 3.54M |
| John Overdeck and David Siegel (founders) | — | 1.88M | 1.99M | 616.12K | 595.93K | 343.31K | — | — |
| David Shaw (founder) | · | 1.1M | 1.06M | 444.49K | — | — | — | — |
| Ray Dalio (founder) | · | 99.58K | 106.59K | 85.62K | — | — | — | — |
| Cliff Asness | · | — | — | 919.96K | 744.01K | — | 828.34K | 813.36K |
| Israel Englander | · | — | — | — | 549.93K | — | — | — |
| Ken Griffin | · | — | — | — | — | 601.2K | — | — |
| Brandon Haley | · | — | — | — | — | 596.82K | — | — |
| Steve Cohen | · | — | — | — | — | — | 300.64K | — |
| George Soros | — | — | — | — | — | — | 60K | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own ALNY?
In their latest 13F filings: Baillie Gifford team (1.28% of the portfolio, $1.4B), Dodge & Cox team (0.27% of the portfolio, $495.1M), David Shaw (founder) (0.21% of the portfolio, $332.4M), Ray Dalio (founder) (0.12% of the portfolio, $30M).
Who bought ALNY last quarter?
Baillie Gifford team (added 125%), Dodge & Cox team (added 2.6%), David Shaw (founder) (added 4.3%). “Last quarter” is each investor's latest reported quarter.
Who sold ALNY last quarter?
Reduced: Ray Dalio (founder) (6.6% fewer shares). Sold out entirely: Ken Fisher (was $1.9M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Alnylam Pharmaceuticals (ALNY)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ALNY/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ALNY by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.